IXC 0.00% 6.6¢ invex therapeutics ltd

Ann: Publication of Invex IIH Phase II Pressure Trial Results, page-4

  1. 390 Posts.
    lightbulb Created with Sketch. 47
    This is a great achievement. Brain is a high impact / Q1 journal with a large audience. If the Phase 2 data is accepted here, then one would expect the Phase 3 to be accepted in an even better journal.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.